Management of primary pulmonary artery sarcomas.
The objective of this review is to determine the outcome of patients with sarcomas involving the main pulmonary artery, pulmonic valve, or right ventricular outflow tract. Survival data were analyzed using an aggregate series derived from the published literature in conjunction with a current series. Median survival was 36.5 +/- 20.2 months for patients undergoing an attempt at curative resection compared with 11 +/- 3 months for those undergoing incomplete resection. Median survival was 24.7 +/- 8.5 months for patients undergoing multimodality treatment compared with 8.0 +/- 1.7 months for patients having single-modality therapy. A complete review of diagnosis, evaluation, treatment, and surveillance of primary pulmonary artery sarcomas follows.
Blackmon
Shanda H
SH
Department of Surgery, The Methodist Hospital, MD Anderson Cancer Center, Houston, Texas, USA. shblackmon@tmhs.org
Rice
David C
DC
Correa
Arlene M
AM
Mehran
Reza
R
Putnam
Joe B
JB
Smythe
W Roy
WR
Walkes
Jon-Cecil
JC
Walsh
Garrett L
GL
Moran
Cesar
C
Singh
Harsh
H
Vaporciyan
Ara A
AA
Reardon
Michael
M
D000328:Adult; D000368:Aged; D000465:Algorithms; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D011651:Pulmonary Artery; D012509:Sarcoma / Q000175:diagnosis / Q000628:therapy; D019043:Vascular Neoplasms / Q000175:diagnosis / Q000628:therapy; D055815:Young Adult